06191102 is referenced by 178 patents and cites 10 patents.

This invention relates the use of glucagon-like peptides such as GLP-1, a GLP-1 analog, or a GLP-1 derivative in methods and compositions for reducing body weight.

Title
Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity
Application Number
8/961405
Publication Number
6191102 (B1)
Application Date
October 30, 1997
Publication Date
February 20, 2001
Inventor
Suad Efendic
Lidingo
US
Richard D DiMarchi
Carmel
IN, US
Agent
Ronald S Maciak
US
Steven G Davis
US
Assignee
Eli Lilly and Company
IN, US
IPC
A01N 37/18
View Original Source